IPGP reported a strong operational rebound for Q3 2025, marked by a swing to profitability following major charges in the prior year. Q3 Net Sales grew 7.6% to $250.8 million, while 9-month sales slightly declined 1.8% to $729.3 million. Gross Margin improved sharply to 39.5%, benefiting from the absence of significant 2024 inventory provisions. Q3 Net Income reached $7.5 million (vs. $233.6 million loss in Q3 2024), translating to Diluted EPS of $0.18. The 9-month period showed Net Income of $17.8 million (vs. $189.3 million loss in 2024).
The business operates as a single segment, he
...